Israel vs Jordan: Previously treated cases tested for RR-/MDR-TB
Israel
100.0%
in 2024
Jordan
100.0%
in 2024
Israel rank
1st
Jordan rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Israel
- Jordan
How they compare
Israel currently reports 100.0% against 100.0% in Jordan, a difference of 0.0%.
The two have swapped places 6 times across 19 shared years of data; in 2005 it was Jordan ahead.
Israel ranks 1st and Jordan ranks 1st of 180 countries.
Across the 3 decades both report, Israel averaged higher in 2 and Jordan in 1.
Head to head by decade
| Decade | Israel | Jordan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 69.0% | 87.0% | 18.0% | Jordan |
| 2010s | 59.6% | 33.1% | 26.4% | Israel |
| 2020s | 100.0% | 58.4% | 41.6% | Israel |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Israel or Jordan?
- Israel, at 100.0% against 100.0% in Jordan as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Israel and Jordan?
- 0.0%, with Israel ahead.
- How many years of comparable data are there for Israel and Jordan?
- 19 years are reported by both, from 2005 to 2024.
- How do Israel and Jordan rank globally for previously treated cases tested for rr-/mdr-tb?
- Israel ranks 1st and Jordan ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.